Collegium Pharmaceutical, Inc. (COLL)

46.57 -0.71 (-1.50%) USD  |  NASDAQ  |  Jan 14, 16:00
46.62 +0.05 (+0.11%) After-Hours: 20:00
More

Collegium Pharmaceutical Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Intuitive Surgical, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Altimmune, Inc. Upgrade